Navigating ‘next frontier’ of AI in medical devices

Related news

Government boosts health innovation funding

Being bad at healthcare innovation ‘is a choice’

Partnership seeks early Alzheimer’s blood test

Call for genomic test for every cancer patient

Patient and Public Involvement 2027 showcase

Webinar: The healthcare ecosystem for innovators

Image: © InnoScot Health
Lauren Brophy, InnoScot Health’s Quality Manager

by InnoScot Health

Tuesday 13th October 2026

A free webinar is to invite MedTech innovators to share in key insights around the next AI-led frontier of adaptive AI in medical device development and deployment.

On Wednesday 28 October, InnoScot Health – a key partner in realising healthcare innovation ambitions for Scotland – will be encouraging forward thinkers to better understand how to ensure the effective advancement of adaptive AI-enabled medical devices in line with regulatory needs.

Such devices use machine learning (ML) algorithms to continuously or iteratively learn from new patient data and update their performance after deployment.

InnoScot Health believes that this requires the careful balancing of cutting-edge thinking with rigorous patient safety frameworks, underpinned by robust clinical evidence. It will be encouraging in-depth discussions around its opportunities and challenges.

Next month’s lunch and learn session, entitled ‘Regulating adaptive AI-enabled medical devices – how to safely navigate the next frontier of development’, takes place from 12-12.45pm and will be presented by InnoScot Health’s Quality Manager, Lauren Brophy.

She will introduce the organisation’s ongoing aim to inspire and collaboratively support innovators working across Scotland’s ‘triple helix’ of NHS, industry, and academia for improved patient outcomes.

Lauren will be joined by a guest speaker from Scarlet – specialists in global certification for AI medical devices who believe that next generation technology can be accessed today when navigating the regulatory approval process correctly.

As part of a highly interactive session including open discussion and Q&A opportunities, the webinar will offer useful insights on:

  • Risk classification – placing AI medical devices in the right Medical Device Regulation (MDR) class
  • Clinical evidence – what's needed for tackling broad AI functionality and claims
  • Post certification – managing AI changes quickly and safely

Presenting on behalf of Scarlet will be Dr Osman El-Koubani, a medical doctor, clinical researcher, and medical device software expert who works as a Clinical Engineer and AI/ML Regulatory Specialist.

You can register here for your place at the seminar.

Lauren said:

“We believe this webinar will provide important insights that will help to extend the knowledge of cutting-edge innovators with an interest in developing adaptive AI-enabled medical devices, and other parties who are simply keen to understand the overarching direction of travel for MedTech.

“Adaptive AI is undoubtedly an exciting area, but one that also requires careful strategy and know-how to navigate successfully.

“Our guest speaker Osman will provide attendees with a deep dive into that process as well as key takeaways as part of Scarlet’s global view of successful AI certification.

“Please register to find out more and we will look forward to welcoming you on 28 October.”

Questions are invited to be pre-submitted via info@innoscot.com

InnoScot Health provides a package of support for ideas that meet its criteria, helping innovators turn concept into reality with the ultimate goal of getting a new product or service onto the market which can make a difference to patients and service users.

 

This article is written as part of a promotional agreement between InnoScot Health and Healthcare News Scotland.

Read more from InnoScot Health: Scotland’s Clinical Entrepreneur initiative returns; Ways to build on healthcare’s digital foundations; Robotic surgery shows pioneering path to the future; Glasgow expertise enables global first heart op; Insight into devices post marketing surveillance; Collaboration on NHS procurement key to healthy future; Spotlight on innovation in neonatal care;